Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
Hinkel R, Batkai S, Bähr A, Bozoglu T, Straub S, Borchert T, Viereck J, Howe A, Hornaschewitz N, Oberberger L, Jurisch V, Kozlik-Feldmann R, Freudenthal F, Ziegler T, Weber C, Sperandio M, Engelhardt S, Laugwitz KL, Moretti A, Klymiuk N, Thum T, Kupatt C. Hinkel R, et al. Among authors: laugwitz kl. J Am Coll Cardiol. 2021 Jun 15;77(23):2923-2935. doi: 10.1016/j.jacc.2021.04.028. J Am Coll Cardiol. 2021. PMID: 34112319 Free article.
Essential myosin light chain as a target for caspase-3 in failing myocardium.
Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, Gillitzer A, Bott-Flügel L, Schömig A, Ungerer M, Laugwitz KL. Moretti A, et al. Among authors: laugwitz kl. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11860-5. doi: 10.1073/pnas.182373099. Epub 2002 Aug 19. Proc Natl Acad Sci U S A. 2002. PMID: 12186978 Free PMC article.
Development. ES cells to the rescue.
Chien KR, Moretti A, Laugwitz KL. Chien KR, et al. Among authors: laugwitz kl. Science. 2004 Oct 8;306(5694):239-40. doi: 10.1126/science.1104769. Science. 2004. PMID: 15472069 No abstract available.
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J, Byrne RA, Tiroch K, Pinieck S, Schulz S, Kufner S, Massberg S, Laugwitz KL, Schömig A, Kastrati A; ISAR-DESIRE 2 Investigators. Mehilli J, et al. Among authors: laugwitz kl. J Am Coll Cardiol. 2010 Jun 15;55(24):2710-6. doi: 10.1016/j.jacc.2010.02.009. Epub 2010 Mar 11. J Am Coll Cardiol. 2010. PMID: 20226618 Free article. Clinical Trial.
2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
Byrne RA, Kastrati A, Tiroch K, Schulz S, Pache J, Pinieck S, Massberg S, Seyfarth M, Laugwitz KL, Birkmeier KA, Schömig A, Mehilli J; ISAR-TEST-2 Investigators. Byrne RA, et al. Among authors: laugwitz kl. J Am Coll Cardiol. 2010 Jun 8;55(23):2536-43. doi: 10.1016/j.jacc.2010.03.020. Epub 2010 Apr 22. J Am Coll Cardiol. 2010. PMID: 20417052 Free article. Clinical Trial.
MicroRNAs in a cardiac loop: progenitor or myocyte?
Evans SM, Moretti A, Laugwitz KL. Evans SM, et al. Among authors: laugwitz kl. Dev Cell. 2010 Dec 14;19(6):787-8. doi: 10.1016/j.devcel.2010.11.015. Dev Cell. 2010. PMID: 21145492 Free PMC article.
Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
Byrne RA, Kastrati A, Massberg S, Wieczorek A, Laugwitz KL, Hadamitzky M, Schulz S, Pache J, Fusaro M, Hausleiter J, Schömig A, Mehilli J; ISAR-TEST 4 Investigators. Byrne RA, et al. Among authors: laugwitz kl. J Am Coll Cardiol. 2011 Sep 20;58(13):1325-31. doi: 10.1016/j.jacc.2011.06.027. J Am Coll Cardiol. 2011. PMID: 21920260 Free article. Clinical Trial.
397 results